1/15
03:21 pm
exel
Exelixis, Inc. (EXEL): A Bull Case Theory [Yahoo! Finance]
Low
Report
Exelixis, Inc. (EXEL): A Bull Case Theory [Yahoo! Finance]
1/14
11:07 am
exel
Exelixis (NASDAQ:EXEL) was given a new $51.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Exelixis (NASDAQ:EXEL) was given a new $51.00 price target on by analysts at Truist Financial Corporation.
1/11
04:16 pm
exel
Exelixis Announces Preliminary Fiscal Year 2025 Financial Results, Provides 2026 Financial Guidance and Outlines Key Priorities and Milestones for 2026 [Yahoo! Finance]
Low
Report
Exelixis Announces Preliminary Fiscal Year 2025 Financial Results, Provides 2026 Financial Guidance and Outlines Key Priorities and Milestones for 2026 [Yahoo! Finance]
1/11
04:00 pm
exel
Exelixis Announces Preliminary Fiscal Year 2025 Financial Results, Provides 2026 Financial Guidance and Outlines Key Priorities and Milestones for 2026
Low
Report
Exelixis Announces Preliminary Fiscal Year 2025 Financial Results, Provides 2026 Financial Guidance and Outlines Key Priorities and Milestones for 2026
1/9
06:11 am
exel
How Natera ctDNA Partnership Around STELLAR-316 At Exelixis (EXEL) Has Changed Its Investment Story [Yahoo! Finance]
Low
Report
How Natera ctDNA Partnership Around STELLAR-316 At Exelixis (EXEL) Has Changed Its Investment Story [Yahoo! Finance]
1/9
12:37 am
exel
Assessing Exelixis (EXEL) Valuation After Zanzalintinib Phase 3 Success And STELLAR-316 Trial Plans [Yahoo! Finance]
Low
Report
Assessing Exelixis (EXEL) Valuation After Zanzalintinib Phase 3 Success And STELLAR-316 Trial Plans [Yahoo! Finance]
1/8
10:57 am
exel
Exelixis (NASDAQ:EXEL) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Exelixis (NASDAQ:EXEL) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/8
08:21 am
exel
Is It Time To Reassess Exelixis (EXEL) After Strong Multi-Year Share Price Gains [Yahoo! Finance]
Medium
Report
Is It Time To Reassess Exelixis (EXEL) After Strong Multi-Year Share Price Gains [Yahoo! Finance]
1/8
08:02 am
exel
Exelixis (NASDAQ:EXEL) had its "equal weight" rating reaffirmed by analysts at Morgan Stanley. They now have a $48.00 price target on the stock, up previously from $45.00.
Medium
Report
Exelixis (NASDAQ:EXEL) had its "equal weight" rating reaffirmed by analysts at Morgan Stanley. They now have a $48.00 price target on the stock, up previously from $45.00.
1/7
09:18 am
exel
Natera to work with Exelixis on latter's zanzalintinib phase 3 trial [Seeking Alpha]
Medium
Report
Natera to work with Exelixis on latter's zanzalintinib phase 3 trial [Seeking Alpha]
1/7
08:35 am
exel
Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer [Yahoo! Finance]
Medium
Report
Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer [Yahoo! Finance]
1/7
08:00 am
exel
Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer
Medium
Report
Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer
1/6
04:05 pm
exel
Exelixis to Present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026
Medium
Report
Exelixis to Present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026
1/5
09:00 am
exel
Exelixis (NASDAQ:EXEL) was downgraded by analysts at Bank of America Corporation from a "neutral" rating to an "underperform" rating. They now have a $41.00 price target on the stock.
Low
Report
Exelixis (NASDAQ:EXEL) was downgraded by analysts at Bank of America Corporation from a "neutral" rating to an "underperform" rating. They now have a $41.00 price target on the stock.
1/5
08:42 am
exel
Exelixis (NASDAQ:EXEL) was given a new $41.00 price target on by analysts at UBS Group AG.
Low
Report
Exelixis (NASDAQ:EXEL) was given a new $41.00 price target on by analysts at UBS Group AG.
1/5
07:17 am
exel
Exelixis (NASDAQ:EXEL) was downgraded by analysts at Citigroup Inc. from a "market outperform" rating to an "underperform" rating.
Low
Report
Exelixis (NASDAQ:EXEL) was downgraded by analysts at Citigroup Inc. from a "market outperform" rating to an "underperform" rating.
12/30
08:11 pm
exel
Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange [Yahoo! Finance]
Low
Report
Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange [Yahoo! Finance]
12/30
06:57 am
exel
Does Exelixis (NASDAQ:EXEL) Deserve A Spot On Your Watchlist? [Yahoo! Finance]
Low
Report
Does Exelixis (NASDAQ:EXEL) Deserve A Spot On Your Watchlist? [Yahoo! Finance]
12/18
07:11 am
exel
Exelixis (NASDAQ:EXEL) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Exelixis (NASDAQ:EXEL) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
12/14
01:26 am
exel
Low
Report
12/11
06:13 am
exel
Exelixis, Inc. (EXEL) Discusses Strategic Approach to Building Next-Generation Oncology Franchises at R&D Day Transcript [Seeking Alpha]
Low
Report
Exelixis, Inc. (EXEL) Discusses Strategic Approach to Building Next-Generation Oncology Franchises at R&D Day Transcript [Seeking Alpha]
12/3
04:05 pm
exel
Exelixis to Webcast Virtual 2025 Research & Development (R&D) Day on Wednesday, December 10, 2025
Low
Report
Exelixis to Webcast Virtual 2025 Research & Development (R&D) Day on Wednesday, December 10, 2025
11/18
09:00 am
exel
Exelixis (NASDAQ:EXEL) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Low
Report
Exelixis (NASDAQ:EXEL) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
11/10
01:43 pm
exel
Exelixis, Inc. (EXEL) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]
Low
Report
Exelixis, Inc. (EXEL) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]
11/7
02:55 pm
exel
Company News for Nov 6, 2025 [Yahoo! Finance]
Low
Report
Company News for Nov 6, 2025 [Yahoo! Finance]